Anteris Technologies Global Corp. (AVR)
8.795
-0.18
(-2.06%)
USD |
NASDAQ |
Aug 24, 16:00
8.795
0.00 (0.00%)
After-Hours: 20:00
Anteris Technologies Global Shareholders Equity (Quarterly) : 251.39M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 251.39M |
| March 31, 2026 | 278.44M |
| December 31, 2025 | -0.093M |
| September 30, 2025 | 3.698M |
| June 30, 2025 | 24.41M |
| March 31, 2025 | 43.26M |
| Date | Value |
|---|---|
| December 31, 2024 | 62.76M |
| September 30, 2024 | 3.150M |
| June 30, 2024 | 2.868M |
| March 31, 2024 | 4.601M |
| December 31, 2023 | 19.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 7.944M |
| Intelligent Bio Solutions, Inc. | 5.511M |
| 20/20 Biolabs, Inc. | 3.159M |
| Quest Diagnostics, Inc. | 7.516B |
| Labcorp Holdings, Inc. | 8.607B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 272.51M |
| Total Liabilities (Quarterly) | 20.84M |
| Debt to Equity Ratio | 0.0132 |
| Current Ratio | 14.20 |
| Net Debt Paydown Yield | -0.03% |